Posted by john on January 29th, 2007 — in Clarityn News
Jan. 29 (Bloomberg) — Schering-Plough Corp.’s fourth- quarter earnings surged 62 percent as the combined sales of its Vytorin and Zetia cholesterol drugs jumped to $1.1 billion.
Net income rose to $204 million, or 12 cents a share, from $126 million, or 7 cents, a year earlier, the Kenilworth, New Jersey-based company said today in a […]
No Comments »
Posted by john on January 26th, 2007 — in Clarityn News
Newswise — Allergy shots are effective and safe for reducing symptoms of hay fever, according to a new review. The injection series caused no deaths and few serious adverse reactions in 51 controlled studies.
Dr. Moises Calderon, of Royal Brompton Hospital in London, and colleagues evaluated the results from randomized, double-blind, placebo-controlled studies in patients with […]
No Comments »
Posted by john on January 22nd, 2007 — in Clarityn News
Heska Corporation (Nasdaq: HSKA) has completed the sale of its rights in a worldwide patent portfolio covering a number of major allergens and the genes that encode them to Allergopharma Joachim Ganzer KG for an undisclosed sum. As part of the agreement, Heska Corporation has exclusively licensed veterinary rights to the portfolio.
“This agreement provides us […]
No Comments »